- Abstract Number: PP12
Healing Together: The Role of Black, Indigenous and People of Color (BIPOC) -Only Chronic Illness Spaces in Comprehensive Care
- Abstract Number: 1338
Health Care Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study
- Abstract Number: 1020
Health Inequalities Exist Between the United States and Europe for Patients with Axial Spondyloarthritis
- Abstract Number: 1913
Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review
- Abstract Number: 1931
Health System Improvement in Appropriate Test Utilization Involving ANA Testing in the Inpatient and Outpatient Setting
- Abstract Number: 2015
Health-Related Quality of Life in Patients with Gout Receiving Treat-to-Target Urate-Lowering Therapy
- Abstract Number: 2403
Health-related Quality of Life in Women with Systemic Lupus Erythematosus with Permanent Skin Damage and Its Association with Self-esteem and Symptoms of Depression and Anxiety – a Cross-sectional Study
- Abstract Number: 1051
Healthcare Costs and Resource Utilization Associated with Long-term Medium-to-high Dose Oral Corticosteroid Use in Patients with Dermatomyositis or Polymyositis
- Abstract Number: 1916
Healthcare Disparities and Clinical Outcomes in Cardiac Sarcoidosis. a Retrospective Cohort Study
- Abstract Number: 1026
Healthcare Utilization and Childhood Opportunity Index in Patients with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus
- Abstract Number: 1343
Heightened Gout Risk in Patients with Rheumatoid Arthritis: A National Cohort Study
- Abstract Number: 0522
Hematological Impact Assessment of Tofacitinib, Baricitinib, and Upadacitinib in Rheumatoid Arthritis Treatment
- Abstract Number: 1958
Hemodynamic Forces: A Novel Cardiac MRI Parameter to Assess Cardiac Involvement in Sarcoidosis Patients
- Abstract Number: 1090
Hepatic Fibrosis Before and During Intensive Urate-lowering with Pegloticase in the Presence and Absence of Methotrexate Co-therapy
- Abstract Number: 0617
Hereditary C1q Deficiency Is Associated with Type 1 Interferon-pathway Activation and a High Risk of Central Nervous System Inflammation
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 181
- Next Page »